Conrad V. Simoben
Impact in
-
- Computational Drug Discovery Methods
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Plant biochemistry and biosynthesis 4
- Histone Deacetylase Inhibitors Research 4
- Phytochemical compounds biological activities 3
- Natural product bioactivities and synthesis 3
-
- Computational Drug Discovery Methods 14
- Co-authors
- Fidele Ntie‐Kang (23 shared papers)Wolfgang Sippl (16 shared papers)Smith B. Babiaka (8 shared papers)Stefan Günther (5 shared papers)Aurélien F. A. Moumbock (5 shared papers)Lydia L. Lifongo (5 shared papers)Akachukwu Ibezim (3 shared papers)Luc Meva’a Mbaze (6 shared papers)
- Journals
- RSC Advances (4 papers)Natural Products and Bioprospecting (3 papers)Molecules (3 papers)Nucleic Acids Research (2 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)
- Partner nations
- GermanyCameroonUnited States
In The Last Decade
Conrad V. Simoben
29 papers receiving 795 citations
Peers
Comparison fields: 5 of 78
- Computational Theory and Mathematics 218
- Pharmacology 167
- Pharmacology 58
- Molecular Biology 429
- Parasitology 40
Countries citing papers authored by Conrad V. Simoben
This map shows the geographic impact of Conrad V. Simoben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad V. Simoben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad V. Simoben more than expected).
Fields of papers citing papers by Conrad V. Simoben
This network shows the impact of papers produced by Conrad V. Simoben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad V. Simoben. The network helps show where Conrad V. Simoben may publish in the future.
Co-authors
The 25 scholars most cited alongside Conrad V. Simoben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 115 | |
| 2 | 2021 | 86 | |
| 3 | 2020 | 80 | |
| 4 | 2014 | 69 | |
| 5 | 2014 | 63 | |
| 6 | 2015 | 41 | |
| 7 | 2018 | 40 | |
| 8 | 2020 | 38 | |
| 9 | 2023 | 34 | |
| 10 | 2018 | 33 | |
| 11 | 2020 | 24 | |
| 12 | 2017 | 22 | |
| 13 | 2016 | 22 | |
| 14 | 2014 | 20 | |
| 15 | 2015 | 18 | |
| 16 | 2014 | 16 | |
| 17 | 2021 | 13 | |
| 18 | 2021 | 11 | |
| 19 | 2014 | 10 | |
| 20 | 2020 | 10 |
About Conrad V. Simoben
Conrad V. Simoben is a scholar working on Molecular Biology, Computational Theory and Mathematics, Pharmacology, Plant Science and Infectious Diseases, having authored 30 papers that have together received 809 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (14 papers), Microbial Natural Products and Biosynthesis (7 papers), Ethnobotanical and Medicinal Plants Studies (6 papers), Plant biochemistry and biosynthesis (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Phytochemical compounds biological activities (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Computational Theory and Mathematics (218 citations), Pharmacology (167 citations), Pharmacology (58 citations), Molecular Biology (429 citations) and Parasitology (40 citations). Conrad V. Simoben has collaborated with scholars based in Germany, Cameroon and United States. Frequent co-authors include Fidele Ntie‐Kang, Wolfgang Sippl, Smith B. Babiaka, Stefan Günther, Aurélien F. A. Moumbock, Lydia L. Lifongo, Akachukwu Ibezim, Luc Meva’a Mbaze, Dina Robaa and Jelena Melesina. Their work appears in journals such as RSC Advances, Natural Products and Bioprospecting, Molecules, Nucleic Acids Research and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.